A Multiepitope Nanovaccine Candidate Adjuvanted with Porcine Ferritin Scaffold for African Swine Fever Virus

<b>Background</b>: African swine fever (ASF) is a highly contagious acute febrile disease with a near 100% mortality rate. There are currently no safe and effective vaccines for this disease. Cellular immunity plays an important role in the process of anti-viral, activating an effective...

Full description

Saved in:
Bibliographic Details
Main Authors: Lidan Sun, Yuping Ding, Jingqi Niu, Yingjun Li, Zeliang Chen
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/13/6/585
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849433866992877568
author Lidan Sun
Yuping Ding
Jingqi Niu
Yingjun Li
Zeliang Chen
author_facet Lidan Sun
Yuping Ding
Jingqi Niu
Yingjun Li
Zeliang Chen
author_sort Lidan Sun
collection DOAJ
description <b>Background</b>: African swine fever (ASF) is a highly contagious acute febrile disease with a near 100% mortality rate. There are currently no safe and effective vaccines for this disease. Cellular immunity plays an important role in the process of anti-viral, activating an effective cellular immune response is a prerequisite for the effectiveness of the vaccine. <b>Methods</b>: To effectively activate cellular immune responses, 133 immunodominant T cell epitopes (TEPs) were identified and synthesized into ten recombinant multi-epitope proteins (MEPs). These MEPs were subsequently conjugated to porcine ferritin (pFTH1) to generate MEPs-pFTH1 nanoparticles. Animal experiments were conducted to evaluate their immunogenicity and biocompatibility. <b>Results</b>: Animal experiments demonstrated that both MEPs and MEPs-pFTH1 nanoparticles induced significant humoral and cellular immune responses. Compared to MEPs monomers, the MEPs-pFTH1 nanoparticles induced a 10- to 100-fold increase in IgG and IgG2a antibody titers (<i>p</i> < 0.05), as well as a significantly higher number of IFN-γ<sup>+</sup> cells. Serum from pigs immunized with MEPs-pFTH1 nanoparticles can significantly inhibit ASFV replication. <b>Conclusions</b>: Our novel self-assembled porcine ferritin nanovaccine candidate can induce strong humoral and cellular immune responses in swine and mice that effectively inhibit ASFV replication. Therefore, the nanovaccine is a highly biocompatible and safe candidate vaccine for ASF that warrants further investigation, such as conducting animal challenge experiments to evaluate the effectiveness of the vaccine.
format Article
id doaj-art-e2515e2edd764a44a08c8d7e88523900
institution Kabale University
issn 2076-393X
language English
publishDate 2025-05-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj-art-e2515e2edd764a44a08c8d7e885239002025-08-20T03:26:52ZengMDPI AGVaccines2076-393X2025-05-0113658510.3390/vaccines13060585A Multiepitope Nanovaccine Candidate Adjuvanted with Porcine Ferritin Scaffold for African Swine Fever VirusLidan Sun0Yuping Ding1Jingqi Niu2Yingjun Li3Zeliang Chen4Key Laboratory of Livestock Infectious Diseases in Northeast China, Ministry of Education, College of Animal Science and Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, ChinaTwins Group Co., Ltd., Nanchang 330046, ChinaKey Laboratory of Livestock Infectious Diseases in Northeast China, Ministry of Education, College of Animal Science and Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, ChinaBeijing Tonghe Litai Biotechnology Co., Ltd., Beijing 102600, ChinaKey Laboratory of Livestock Infectious Diseases in Northeast China, Ministry of Education, College of Animal Science and Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, China<b>Background</b>: African swine fever (ASF) is a highly contagious acute febrile disease with a near 100% mortality rate. There are currently no safe and effective vaccines for this disease. Cellular immunity plays an important role in the process of anti-viral, activating an effective cellular immune response is a prerequisite for the effectiveness of the vaccine. <b>Methods</b>: To effectively activate cellular immune responses, 133 immunodominant T cell epitopes (TEPs) were identified and synthesized into ten recombinant multi-epitope proteins (MEPs). These MEPs were subsequently conjugated to porcine ferritin (pFTH1) to generate MEPs-pFTH1 nanoparticles. Animal experiments were conducted to evaluate their immunogenicity and biocompatibility. <b>Results</b>: Animal experiments demonstrated that both MEPs and MEPs-pFTH1 nanoparticles induced significant humoral and cellular immune responses. Compared to MEPs monomers, the MEPs-pFTH1 nanoparticles induced a 10- to 100-fold increase in IgG and IgG2a antibody titers (<i>p</i> < 0.05), as well as a significantly higher number of IFN-γ<sup>+</sup> cells. Serum from pigs immunized with MEPs-pFTH1 nanoparticles can significantly inhibit ASFV replication. <b>Conclusions</b>: Our novel self-assembled porcine ferritin nanovaccine candidate can induce strong humoral and cellular immune responses in swine and mice that effectively inhibit ASFV replication. Therefore, the nanovaccine is a highly biocompatible and safe candidate vaccine for ASF that warrants further investigation, such as conducting animal challenge experiments to evaluate the effectiveness of the vaccine.https://www.mdpi.com/2076-393X/13/6/585African swine fever (ASF)NanovaccineT-cell epitopesporcine ferritin (pFTH1)IFN-γ<sup>+</sup>
spellingShingle Lidan Sun
Yuping Ding
Jingqi Niu
Yingjun Li
Zeliang Chen
A Multiepitope Nanovaccine Candidate Adjuvanted with Porcine Ferritin Scaffold for African Swine Fever Virus
Vaccines
African swine fever (ASF)
Nanovaccine
T-cell epitopes
porcine ferritin (pFTH1)
IFN-γ<sup>+</sup>
title A Multiepitope Nanovaccine Candidate Adjuvanted with Porcine Ferritin Scaffold for African Swine Fever Virus
title_full A Multiepitope Nanovaccine Candidate Adjuvanted with Porcine Ferritin Scaffold for African Swine Fever Virus
title_fullStr A Multiepitope Nanovaccine Candidate Adjuvanted with Porcine Ferritin Scaffold for African Swine Fever Virus
title_full_unstemmed A Multiepitope Nanovaccine Candidate Adjuvanted with Porcine Ferritin Scaffold for African Swine Fever Virus
title_short A Multiepitope Nanovaccine Candidate Adjuvanted with Porcine Ferritin Scaffold for African Swine Fever Virus
title_sort multiepitope nanovaccine candidate adjuvanted with porcine ferritin scaffold for african swine fever virus
topic African swine fever (ASF)
Nanovaccine
T-cell epitopes
porcine ferritin (pFTH1)
IFN-γ<sup>+</sup>
url https://www.mdpi.com/2076-393X/13/6/585
work_keys_str_mv AT lidansun amultiepitopenanovaccinecandidateadjuvantedwithporcineferritinscaffoldforafricanswinefevervirus
AT yupingding amultiepitopenanovaccinecandidateadjuvantedwithporcineferritinscaffoldforafricanswinefevervirus
AT jingqiniu amultiepitopenanovaccinecandidateadjuvantedwithporcineferritinscaffoldforafricanswinefevervirus
AT yingjunli amultiepitopenanovaccinecandidateadjuvantedwithporcineferritinscaffoldforafricanswinefevervirus
AT zeliangchen amultiepitopenanovaccinecandidateadjuvantedwithporcineferritinscaffoldforafricanswinefevervirus
AT lidansun multiepitopenanovaccinecandidateadjuvantedwithporcineferritinscaffoldforafricanswinefevervirus
AT yupingding multiepitopenanovaccinecandidateadjuvantedwithporcineferritinscaffoldforafricanswinefevervirus
AT jingqiniu multiepitopenanovaccinecandidateadjuvantedwithporcineferritinscaffoldforafricanswinefevervirus
AT yingjunli multiepitopenanovaccinecandidateadjuvantedwithporcineferritinscaffoldforafricanswinefevervirus
AT zeliangchen multiepitopenanovaccinecandidateadjuvantedwithporcineferritinscaffoldforafricanswinefevervirus